Trinity Biotech | TRIB - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Abbott USD 1.85B 399M 2026-03
Bayer EUR 1.11B 1.65B 2025-12
Bio-Rad Laboratories USD 53.9M 10M 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
J&J USD 6.62B 1.03B 2026-03
Mesa Laboratories USD 5.78M 2.27M 2024-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Plus Therapeutics USD -5.74M 1.26M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Siemens EUR 2.57B 3M 2025-12
Surmodics USD 58K 5.7M 2025-06
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Tosoh JPY 25.15B 3.51B 2025-12
Trinity Biotech USD -509K 6.27M 2025-09
Veracyte USD 19.08M 5.55M 2026-03